Malignant Tumor of Breast
10
2
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Lifestyles and Breast Cancer
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
Implantation of CEST and CESL MRI Methods for Detection of Breast Tumors
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors